Cargando…
Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
AIMS: Neprilysin degrades natriuretic peptides in circulation and is also suggested to degrade the gut hormones gastrin and cholecystokinin. Neprilysin inhibition has become a therapeutic strategy and thus a regimen in need of further testing in terms of other hormonal axes besides natriuretic pepti...
Autores principales: | Andersen, Ulrik Ø, Terzic, Dijana, Wewer Albrechtsen, Nicolai Jacob, Dall Mark, Peter, Plomgaard, Peter, Rehfeld, Jens F, Gustafsson, Finn, Goetze, Jens P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274559/ https://www.ncbi.nlm.nih.gov/pubmed/32348960 http://dx.doi.org/10.1530/EC-19-0563 |
Ejemplares similares
-
Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy
por: Rehfeld, Jens F
Publicado: (2019) -
Cholecystokinin and the hormone concept
por: Rehfeld, Jens F
Publicado: (2021) -
Gastrin and the Moderate Hypergastrinemias
por: Rehfeld, Jens F.
Publicado: (2021) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Cholecystokinin—From Local Gut Hormone to Ubiquitous Messenger
por: Rehfeld, Jens F.
Publicado: (2017)